"The Broad Institute of MIT and Harvard, Rockefeller University, Harvard University, and MIT have turned over 22 of their CRISPR-Cas9 patents for consideration to be part of a shared, global licensing platform. The Wall Street Journal reports that “the move comes amid growing concerns that the logjam over rights to the technology may hinder breakthroughs in disease treatment.”
“We look forward to working with others to ensure the widest possible access to all key CRISPR intellectual property,” says Chief Business Officer of the Broad Institute Issi Rozen in a news release issued today (July 10).
Groups seeking to commercialize CRISPR technology are often required to go to more than one institution for licensing, according to the Broad’s statement, given that there are 18 different organizations in the U.S. that hold more than 60 CRISPR-Cas9 patents. A pool would simplify this process by creating “a one-stop shop for commercial users.”"
